1,721,039 research outputs found
Pelvic exenteration in gynecologic oncology. Review.
No full textPelvic exenteration is still indicated in the treatment of gynecological cancer, in patients with pelvic resectable disease, after the failure of standard treatment. The reported survival ranges from 20 to 60% and has been increasing in the last 15 years; the prognostic factors more frequently described are margin status, time from diagnosis or radiotherapy, lesion size, preoperative side-wall fixation. The role of palliative exenteration in patients with non-resectable disease and/or nodal metastases is discussed. Survival and morbidity in elderly patients are comparable to the younger group and age cannot be considered as an exclusion criteria. Gastrointestinal, urinary and infectious complications are still considerable, but morbidity and mortality have been reduced by surgical and intensive care developments. New surgical techniques, i.e. vaginal reconstruction and continent urinary diversions, have improved quality of life, especially in younger patients, with longer expected survival
Le neoplasie dell’endometrio: la chemioterapia antiblastica.
No full textLe neoplasie dell’endometrio: la chemioterapia antiblastica
Carcinoma ovarico allo stadio avanzato: razionale della citoriduzione chirurgica e analisi dei fattori prognostici.
No full textCarcinoma ovarico allo stadio avanzato: razionale della citoriduzione chirurgica e analisi dei fattori prognostici
Oral Ondansetron and intravenous Dexamethasone in the prevention of cisplatin-induced emesis.
No full textFifty-eight previously untreated patients with gynecological cancer, assigned to cisplatin-based chemotherapy (40-80 mg/m2), received the following antiemetic treatment: day 0, oral ondansetron 8 mg 3 times/day + intravenous dexamethasone 16 mg; days 1-7, oral ondansetron 8 mg twice/day. In cycle 1 complete or major control (0-2 emetic episodes) was achieved in 94.6% of the patients in the acute phase (day 0) and in 89.2% in the delayed phase (day 1-7). In the subgroup receiving cisplatin > or = 75 mg/m2 the effect on acute and delayed emesis decreased significantly with subsequent courses. Reversible side effects were observed in 8.9% of the cases. Oral ondansetron was efficacious, well tolerated and is worth testing further in randomized trials with intravenous therapy
INGUINO-FEMORAL LYMPHADENECTOMY FOR VULVAR CARCINOMA WITH OR WITHOUT SAPHENECTOMY: A RANDOMISED STUDY
No full textLaparoscopic and laparotomic second look surgery for ovarian cancer:a report of 49 consecutive patients.
No full textLaparoscopy and laparotomic second look surgery for ovarian cancer: a report of 49 consecutive patients
Chemotherapy in Uterine Mesenchymal Tumors
No full textComparison between single-agent and combination chemiotherapy against uterine mesenchymal tumors. Doxorubicine for LMS and ifosfamide and cisplatin for MMT are the most effective antineoplastic drugs in single-agent chemiotherapy. Combination chemiotherapy increases response rate as well as toxicity, but the impact on survival is unclear
Immunità in oncologia ginecologica : influenza della neoplasia e dei trattamenti.
No full textImmunità in oncologia ginecologica: influenza della neoplasia e dei trattamenti
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
- …
